Log in to save to my catalogue

Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine

Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_74cfc9b904474091b17850c1e5910004

Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

There is a clear need for novel approaches to malaria vaccine development. We aimed to develop a genetically attenuated blood-stage vaccine and test its safety, infectivity, and immunogenicity in healthy volunteers. Our approach was to target the gene encoding the knob-associated histidine-rich protein (KAHRP), which is responsible for the assembly...

Alternative Titles

Full title

Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_74cfc9b904474091b17850c1e5910004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_74cfc9b904474091b17850c1e5910004

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-021-02150-x

How to access this item